SCHEMBL31565927

SCHEMBL31565927

CN(C)CC(=O)NCC(=O)N1CCc2ccc(Oc3ccc(C(F)(F)F)cc3)cc2C1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ GHSR Q92847 2/20 0.43
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ SCN9A Q15858 1/20 0.41
▸ ESR1 P03372 1/20 0.40
▸ ESR2 Q92731 1/20 0.40
▸ LIPE Q05469 1/20 0.39
▸ MGLL Q99685 1/20 0.39
▸ ABHD6 Q9BV23 1/20 0.39
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ AHCY P23526 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31565830 0.86 ALDH1A1 (0.47) ALDH1A1L3MBTL1GHSRMEN1KMT2A
SCHEMBL31566054 0.85 ALDH1A1 (0.46) ALDH1A1L3MBTL1GHSRMEN1KMT2A
SCHEMBL31566040 0.85 ALDH1A1 (0.46) ALDH1A1L3MBTL1GHSRMEN1KMT2A
SCHEMBL31565825 0.85 ALDH1A1 (0.43) ALDH1A1L3MBTL1GHSRMEN1KMT2A
SCHEMBL31566066 0.84 GHSR (0.49) ALDH1A1L3MBTL1GHSRSCN9AESR1
SCHEMBL31565905 0.84 ALDH1A1 (0.45) ALDH1A1L3MBTL1GHSRMEN1KMT2A
SCHEMBL31565855 0.83 ALDH1A1 (0.45) ALDH1A1L3MBTL1GHSRSCN9AESR1
SCHEMBL31565889 0.82 ESR1 (0.47) ALDH1A1L3MBTL1GHSRKMT2AESR1
SCHEMBL31565916 0.81 ALDH1A1 (0.44) ALDH1A1L3MBTL1GHSRKDM4ESCN9A
SCHEMBL31565894 0.81 NPC1 (0.44) ALDH1A1L3MBTL1GHSRSCN9AESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129028-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2025-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129028-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR YAP1, YES1, LATS1 ALDH1A1 2760/4885L3MBTL1 1076/4885GHSR 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback